Streetbeat News

Products Services

MLRT

MetAlert, Inc (OTC:MLRT) has received and delivered its first commercial order for the GunAlert firearm recovery device from Range USA. The device, developed by MetAlert's subsidiary Level 2 Security, uses motion detection and GPS technology to monitor unauthorized use and movement of firearms. The company plans to work with law enforcement and media to promote the technology.

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 12:00 pm

BBY

Best Buy Co Inc (NYSE:BBY) will start selling the Dexcom G7 Continuous Glucose Monitoring System (CGM) online, marking its first foray into prescription-based medical devices. The sale will be facilitated by Wheel, a virtual care platform, and HealthDyne, a pharmacy technology provider. This move aligns with Best Buy Health's goal to facilitate care at home.

Portfolio Pulse from Shivani Kumaresan

October 09, 2023 | 11:54 am

MSFT

OpenAI's ChatGPT Vision, backed by Microsoft Corp. (NASDAQ:MSFT), is a new image analyzer tool that can perform a range of tasks such as generating code from a flow chart, understanding complex PowerPoint slides and memes, analyzing nutrition, translating manuscripts, and even finding Waldo. The tool can take screenshots from Figma and generate code, understand complex PowerPoint slides, provide art critiques, analyze nutrition in food items, translate manuscripts, decode complex movie outlines like Christopher Nolan's Inception, explain memes, and find Waldo in images.

Portfolio Pulse from Rounak Jain

October 09, 2023 | 11:52 am

RPHM

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) has announced the last patient last visit (LPLV) in the pivotal STRIDE study of mavodelpar in Primary Mitochondrial Myopathies (PMM). The topline data results from the study are expected in December 2023.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:51 am

MSFT

NVDA

Nvidia Corp. (NASDAQ:NVDA) shares are falling in premarket trading due to a report that Microsoft Corp. (NASDAQ:MSFT), a major customer for Nvidia’s AI chip, will launch its own in-house AI chip next month. The report suggests that Microsoft has been working on this chip for years. Nvidia's stock could also be reacting to the Israel-Hamas conflict that is affecting growth stocks.

Portfolio Pulse from Shanthi Rexaline

October 09, 2023 | 11:38 am

MDWD

MediWound is addressing the emergency demand for NexoBrid, a product used to treat burn casualties, due to the ongoing war in Israel. The company is ramping up production to meet the increased demand.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:37 am

JNJ

Johnson & Johnson's Janssen Pharmaceuticals announced that it will feature 30 company-sponsored presentations at the European Academy of Dermatology and Venereology Congress.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:35 am

CMI

Cummins Inc. is set to unveil a proof-of-concept drivetrain for defense applications at the 2024 Annual AUSA Conference in Washington, DC, from October 9-11.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:33 am

BBIO

BridgeBio Pharma, Inc. (NASDAQ:BBIO) has shared new long-term data from its Phase 2 trial in patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). The data remains consistent with earlier results, showing a well-tolerated safety profile and encouraging preliminary efficacy. Early changes in glycosylated ⍺DG levels at 3 months appear to be associated with ambulatory improvements at 9 months, supporting the potential use of glycosylated ⍺DG levels as a surrogate endpoint in the ongoing Phase 3 study for accelerated approval.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:32 am

ALNY

Alnylam Pharmaceuticals has received a Complete Response Letter (CRL) from the FDA regarding its Supplemental New Drug Application for Patisiran, used for the treatment of cardiomyopathy of ATTR amyloidosis. The CRL does not affect the commercial availability of ONPATTRO, another drug approved by the FDA for the treatment of polyneuropathy of hereditary ATTR amyloidosis in adults.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 11:32 am